Preferred Label : Pioglitazone;

MeSH definition : A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.;

MeSH synonym : 5-(4-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione;

MeSH hyponym : U72,107A; U-72107A; U72107A; AD-4833; AD4833;

MeSH Related Number : 111025-46-8 (Pioglitazone); 112529-15-4 (Pioglitazone Hydrochloride); JQT35NPK6C;

UNII : X4OV71U42S;

Details


Main resources

You can consult :

A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.

https://www.cochrane.org/fr/CD013516/ENDOC_la-pioglitazone-previent-elle-ou-retarde-t-elle-le-diabete-de-type-2-et-ses-complications-chez-les
2020
France
United Kingdom
review of literature
french abstract
Diabetes mellitus type 2
diabetes mellitus, type 2
diabetes non-insulin dependent
diabetes mellitus without complication
Pioglitazone
diabetic complications
persons
diabetes complications

---
https://www.ema.europa.eu/medicines/human/EPAR/Sepioglin
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
syndication feed
thiazolidinediones
thiazolidinediones
administration, oral
drug approval
treatment outcome
drugs, generic
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)
pioglitazone
adult
diabetes mellitus, type 2
drug therapy, combination
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
hypoglycemic agents
hypoglycemic agents
breast feeding
aged
pregnancy
drug interactions
overweight
continuity of patient care
ppar gamma
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Incresync
2013
United Kingdom
French
English
alogliptin
drug combinations
alogliptin
pioglitazone and alogliptin
drug approval
europe
treatment outcome
adult
drug therapy, combination
diabetes mellitus, type 2
hypoglycemic agents
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
administration, oral
product surveillance, postmarketing
continuity of patient care
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
syndication feed
thiazolidinediones
thiazolidinediones
piperidines
piperidines
uracil
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Actos
2012
United Kingdom
French
English
syndication feed
diabetes mellitus, type 2
thiazolidinediones
hypoglycemic agents
hypoglycemic agents
thiazolidinediones
drug therapy, combination
drug evaluation
treatment outcome
overweight
adult
aged
administration, oral
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
drug evaluation, preclinical
drug approval
drug labeling
pioglitazone
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
drug evaluation
summary of product characteristics
package leaflet
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Competact
2012
United Kingdom
English
French
syndication feed
diabetes mellitus, type 2
thiazolidinediones
hypoglycemic agents
metformin
treatment outcome
drug evaluation
drug combinations
adult
administration, oral
tablets
aged
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
thiazolidinediones
metformin
hypoglycemic agents
drug evaluation, preclinical
drug labeling
drug approval
overweight
metformin and pioglitazone
Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
drug evaluation
summary of product characteristics
package leaflet
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/glidipion-previously-pioglitazone-actavis-group
2012
false
United Kingdom
English
French
drug evaluation
summary of product characteristics
package leaflet
syndication feed
thiazolidinediones
thiazolidinediones
administration, oral
drugs, generic
drug approval
treatment outcome
pioglitazone
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)
diabetes mellitus, type 2
adult
aged
overweight
hypoglycemic agents
hypoglycemic agents
drug therapy, combination
ppar gamma
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
continuity of patient care
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Glubrava
2012
United Kingdom
French
English
syndication feed
hypoglycemic agents
metformin
adult
drug combinations
breast feeding
pregnancy
drug approval
tablets
diabetes mellitus, type 2
drug labeling
treatment outcome
drug evaluation
drug evaluation, preclinical
hypoglycemic agents
thiazolidinediones
metformin
drug interactions
aged
administration, oral
overweight
thiazolidinediones
metformin and pioglitazone
Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
package leaflet
summary of product characteristics
drug evaluation
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/pioglitazone-actavis
2012
false
United Kingdom
English
French
summary of product characteristics
drug evaluation
package leaflet
syndication feed
breast feeding
drug interactions
drug evaluation, preclinical
thiazolidinediones
thiazolidinediones
administration, oral
drugs, generic
drug approval
treatment outcome
adult
aged
diabetes mellitus, type 2
overweight
drug therapy, combination
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
pioglitazone
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)
hypoglycemic agents
hypoglycemic agents
continuity of patient care
ppar gamma
pregnancy
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/pioglitazone-accord
2012
false
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
syndication feed
ppar gamma
thiazolidinediones
thiazolidinediones
drug approval
administration, oral
treatment outcome
pioglitazone
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)
adult
aged
diabetes mellitus, type 2
overweight
drugs, generic
hypoglycemic agents
hypoglycemic agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
continuity of patient care
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Paglitaz
2012
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
syndication feed
thiazolidinediones
thiazolidinediones
drug interactions
pregnancy
breast feeding
continuity of patient care
hypoglycemic agents
hypoglycemic agents
drug evaluation, preclinical
ppar gamma
administration, oral
drugs, generic
drug approval
treatment outcome
pioglitazone
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)
drug therapy, combination
adult
diabetes mellitus, type 2
aged
overweight
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Tandemact
2012
United Kingdom
English
French
syndication feed
Contraindications, Procedure
drug evaluation
thiazolidinediones
hypoglycemic agents
diabetes mellitus, type 2
sulfonylurea compounds
adult
treatment outcome
drug combinations
tablets
administration, oral
thiazolidinediones
thiazolidinediones
thiazolidinediones
thiazolidinediones
aged
hypoglycemic agents
hypoglycemic agents
hypoglycemic agents
hypoglycemic agents
sulfonylurea compounds
sulfonylurea compounds
sulfonylurea compounds
sulfonylurea compounds
sulfonylurea compounds
hypoglycemic agents
thiazolidinediones
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
hypoglycemic agents
sulfonylurea compounds
thiazolidinediones
thiazolidinediones
sulfonylurea compounds
hypoglycemic agents
drug evaluation, preclinical
drug labeling
drug approval
glimepiride
glimepiride and pioglitazone
sulfonylurea compounds
Pioglitazone Hydrochloride
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)
Product containing glimepiride and pioglitazone (medicinal product)
drug evaluation
package leaflet
summary of product characteristics
Contraindications, Drug
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Pioglitazone-Teva-Pharma
2012
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
syndication feed
pregnancy
breast feeding
drug evaluation, preclinical
therapeutic equivalency
ppar gamma
aged
drug approval
treatment outcome
pioglitazone
administration, oral
drugs, generic
hypoglycemic agents
hypoglycemic agents
thiazolidinediones
thiazolidinediones
diabetes mellitus, type 2
adult
drug interactions
overweight
drug therapy, combination
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Pioglitazone-Teva
2012
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
syndication feed
drug therapy, combination
ppar gamma
drug approval
treatment outcome
administration, oral
drugs, generic
pioglitazone
diabetes mellitus, type 2
overweight
adult
aged
therapeutic equivalency
hypoglycemic agents
hypoglycemic agents
thiazolidinediones
thiazolidinediones
drug evaluation, preclinical
drug interactions
pregnancy
breast feeding
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Glustin
2012
Non renseigné
French
English
syndication feed
thiazolidinediones
thiazolidinediones
hypoglycemic agents
hypoglycemic agents
treatment outcome
drug evaluation
drug approval
drug labeling
tablets
overweight
adult
aged
drug interactions
pregnancy
breast feeding
drug therapy, combination
drug evaluation, preclinical
diabetes mellitus, type 2
ppar gamma
pioglitazone
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
drug evaluation
summary of product characteristics
package leaflet
Pioglitazone
Pioglitazone

---
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/14115a-fra.php
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/15854a-fra.php
2012
Canada
French
English
pharmacovigilance note
popular works
Contraindications, Procedure
Pioglitazone Hydrochloride
urinary bladder neoplasms
administration, oral
pioglitazone
hypoglycemic agents
thiazolidinediones
diabetes mellitus, type 2
thiazolidinediones
hypoglycemic agents
risk factors
urinary bladder neoplasms
Pioglitazone Hydrochloride
risk assessment
Contraindications, Drug
Pioglitazone
Pioglitazone

---
http://www.has-sante.fr/portail/jcms/c_1171505/competact-15-mg-/-850-mg-pioglitazone/metformine-antidiabetique
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-01/competact_06-07-2011_synthese_ct10278.pdf
2011
France
French
administration, oral
drug combinations
metformin
metformin
insurance, health, reimbursement
hypoglycemic agents
hypoglycemic agents
thiazolidinediones
thiazolidinediones
metformin and pioglitazone
diabetes mellitus, type 2
overweight
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
guidelines for drug use
evaluation of the transparency committee
Pioglitazone
Pioglitazone

---
http://www.has-sante.fr/portail/jcms/c_1171497/actos-pioglitazone-antidiabetique
2011
France
French
evaluation of the transparency committee
guidelines for drug use
administration, oral
hypoglycemic agents
hypoglycemic agents
insurance, health, reimbursement
pioglitazone
diabetes mellitus, type 2
overweight
thiazolidinediones
thiazolidinediones
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
Pioglitazone
Pioglitazone

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-08/competact_-_ct-10278.pdf
http://www.has-sante.fr/portail/jcms/c_1078997/competact
2011
France
French
evaluation of the transparency committee
drug combinations
thiazolidinediones
diabetes mellitus, type 2
treatment outcome
metformin
administration, oral
hypoglycemic agents
metformin and pioglitazone
insurance, health, reimbursement
overweight
adult
aged
Pioglitazone Hydrochloride
Pioglitazone

---
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/13617a-fra.php
2011
Canada
French
English
pharmacovigilance note
risk
canada
administration, oral
Pioglitazone Hydrochloride
hypoglycemic agents
thiazolidinediones
urinary bladder neoplasms
pioglitazone
Pioglitazone

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2011-risque-cancer-vessie-pioglitazone-diabetiques
2011
France
technical report
Pioglitazone
france
french
persons
France
risk
neoplasm, malignant
urinary bladder cancer
Bladder cancer
diabetes mellitus
France
urinary bladder neoplasms
malignant neoplasm of bladder
France
France
Diabetes

---
http://www.has-sante.fr/portail/jcms/c_1081110/actos
2011
France
tablets
Pioglitazone

---
http://www.ameli.fr/fileadmin/user_upload/documents/RapportEtudeCNAMTS-Pioglitazone-juin-20113.pdf
2011
France
French
technical report
Pioglitazone Hydrochloride
hypoglycemic agents
thiazolidinediones
urinary bladder neoplasms
cohort studies
incidence
urinary bladder neoplasms
Pioglitazone

---
http://www.fmoq.org/Lists/FMOQDocumentLibrary/fr/Le%20M%C3%A9decin%20du%20Qu%C3%A9bec/Archives/2000%20-%202009/025-026InfoPoems0509.pdf
2009
false
false
Canada
French
diabetes complications
naproxen
gout suppressants
diabetes mellitus
Evidence-Based medicine
treatment outcome
hypoglycemic agents
thiazolidinediones
cardiovascular diseases
diabetes mellitus
administration, oral
prednisolone
gout
thiazolidinediones
Pioglitazone Hydrochloride
critical appraisal or critical reading
Pioglitazone

---
http://www.campus-umvf.cnge.fr/materiel/Approche_factuelle_glitazones%20_diabetiques.pdf
2008
false
France
French
diabetes mellitus, type 2
hypoglycemic agents
thiazolidinediones
metformin
thiazoles
thiazolidinediones
Pioglitazone Hydrochloride
journal article
Rosiglitazone
Pioglitazone

---
https://www.minerva-ebp.be/fr/article/552
2008
false
false
minerva-ebm.be
Belgium
French
cardiovascular risk
thiazolidinediones
hypoglycemic agents
diabetes mellitus, type 2
cardiovascular diseases
risk factors
Pioglitazone Hydrochloride
risk assessment
critical appraisal or critical reading
comparative study
Rosiglitazone
Pioglitazone

---
https://www.minerva-ebp.be/fr/article/689
2006
false
false
minerva-ebm.be
Belgium
French
diabetes complications
thiazolidinediones
diabetes mellitus, type 2
hypoglycemic agents
myocardial infarction
stroke
treatment outcome
diabetes mellitus, type 2
risk factors
Pioglitazone Hydrochloride
critical appraisal or critical reading
Pioglitazone

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.